๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Paternal bias in parental origin of HRAS mutations in Costello syndrome

โœ Scribed by Katia Sol-Church; Deborah L. Stabley; Linda Nicholson; Iris L. Gonzalez; Karen W. Gripp


Book ID
102260297
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
223 KB
Volume
27
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

โœฆ Synopsis


Communicated by Haig H. Kazazian

Costello syndrome (CS) is a rare congenital condition caused by heterozygous de novo missense mutations affecting the codon for glycine 12 or 13 of the HRAS gene. We have identified 39 CS patients harboring the p.Gly12Ser mutation (NM_005343.2:c.34 G4A), two patients with c.35G4C mutations resulting in p.Gly12Ala substitutions, and one patient carrying the p.Gly13Cys substitution (c.37G4A). We analyzed the region flanking the mutated sites in 42 probands and 59 parents, and used four polymorphic markers to trace the parental origin of the germline mutations: one highly polymorphic hexanucleotide (GGGCCT) repeat region, defining three alleles with different numbers of repeat units (two, three, or four), and three SNPs. One of the SNPs, rs12628 (c.81T4C), was found in strong linkage disequilibrium with the hexanucleotide repeat region. Out of a total of 24 probands with polymorphic markers, 16 informative families were tested and the paternal origin of the germline mutation was found in 14 CS probands; a distribution that is neither consistent with an equal likelihood of mutations arising in either parent (P 5 0.0018), nor with exclusive paternal origin. Hum Mutat 27(8), 736-741, 2006.


๐Ÿ“œ SIMILAR VOLUMES


Diversity, parental germline origin, and
โœ Giuseppe Zampino; Francesca Pantaleoni; Claudio Carta; Gilda Cobellis; Isabella ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 339 KB

Activating mutations in v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS) have recently been identified as the molecular cause underlying Costello syndrome (CS). To further investigate the phenotypic spectrum associated with germline HRAS mutations and characterize their molecular diversity,